Annual Drug Patent Expirations for OXTELLAR+XR
Oxtellar Xr is a drug marketed by Supernus Pharms and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug and one Paragraph IV challenge.
OXTELLAR XR drug price trends.
Drug patent litigation for OXTELLAR XR.
This drug has fourteen patent family members in ten countries.
The generic ingredient in OXTELLAR XR is oxcarbazepine. One supplier is listed for this compound. Additional details are available on the oxcarbazepine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com